MedTrace Logo

Vasopressor Infusion in Cesarean Delivery

NCT03248791 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-09-27

No results posted yet for this study

Summary

Comparison will be conducted between continuous variable infusions of both drugs (Phenylephrine and Norepinephrine) with starting doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylaxis against Post-spinal hypotension during cesarean delivery.

Conditions

  • Cesarean Section Complications
  • Spinal Anesthesia

Interventions

DRUG

Phenylephrine

Phenylephrine variable infusion with a starting rate of 0.75 mcg/Kg/min.

DRUG

Norepinephrine

Norepinephrine variable infusion with a starting rate of 0.1 mcg/Kg/min.

DRUG

Bupivacaine

Bupivacaine will be injected in the subarachnoid space with a dose of 10 mg

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Mukhtar, Professor · Head of research committee section in anesthesia department

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-20
Primary Completion
2022-03-01
Completion
2022-03-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03248791 on ClinicalTrials.gov